Inactive Instrument

Insiders Bio-Path Holdings Inc OTC Bulletin Board

Equities

BPTH

US09057N1028

End-of-day quote OTC Bulletin Board Other stock markets
- ^USD	-

06-14	Bio-Path Holdings Presents Data from Ongoing Phase 2 Combination Study of Prexigebersen for Treatment of Acute Myeloid Leukemia At European Hematology Association Congress	CI
06-05	Bio-Path Holdings, Inc. announced that it has received $4.000001 million in funding	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Bio-Path Holdings, Inc. Appoints Aline Sherwood to its Board of Directors	06/04/22	CI
Bio-Path Holdings, Inc. Announces Resignation of Martina Molsbergen as Member of the Board and All Committees of the Board	18/02/22	CI
Bio-Path Holdings, Inc. Announces Board Changes	15/10/19	CI
Bio-Path Holdings, Inc. Appoints Paul D. Aubert as Director	21/12/18	CI
Bio-Path Holdings, Inc. Appoints Dr. Jason B. Fleming to its Scientific Advisory Board	16/08/18	CI
Bio-Path Holdings, Inc. Appoints Anas Younes to Scientific Advisory Board	10/05/18	CI
Bio-Path Holdings, Inc. Appoints Paul Aubert to Its Board of Directors	05/02/18	CI
Bio-Path Holdings, Inc. Announces Resignation of Ulrich W. Mueller as Chief Operating Officer	06/09/17	CI
Bio-Path Holdings, Inc. Announces Resignation of Directors	16/08/17	CI
Bio-Path Holdings, Inc. Appoints Mark Colonnese to its Board of Directors	17/07/17	CI
Bio-Path Holdings Announces the Appointment of William Hahne as Vice President of Clinical Development	17/04/17	CI
Bio-Path Holdings Appoints Dr. Craig Hooper to Scientific Advisory Board	21/02/17	CI
Bio-Path Holdings, Inc. Announces Board Appointments	31/08/15	CI
Bio-Path Holdings, Inc. Appoints Tara Sadeghi as Director of Clinical Operations	30/04/15	CI
Bio-Path Holdings, Inc. Announces Board Changes	03/11/14	CI
Bio-Path Holdings, Inc. Announces Resignation of Douglas P. Morris as Vice President of Corporate Development and Secretary, Effective June 30, 2014	03/07/14	CI
Bio-Path Holdings, Inc. Appoints Ulrich W. Mueller as Chief Operating Officer	26/03/14	CI
Bio-Path Holdings, Inc. Announces Management Appointments	13/02/14	CI
Bio-Path Holdings, Inc. Elects Michael J. Garrison as Director	17/12/12	CI
Bio-Path Holdings, Inc. Appoints Michael J. Garrison as Director	03/10/12	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Bio-Path Holdings Inc OTC Bulletin Board

Equities

BPTH

US09057N1028

Insiders

Filters